Laboratorio Reig (RJF) | Stock Overview & Key Data
Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare
Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare
Laboratorio Reig Performance Comparison
Stock Range
Today's Range
Low: €2.76
High: €2.80
on September 23, 2025
52 Week Range
Low: €2.46
High: €3.40
on January 16, 2025
on June 6, 2025
All-Time High: €55.00 on November 25, 2002
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€229.5M
EPS
0.08
P/E Ratio (TTM)
35.25
Forward P/E
13.43
P/B Ratio
1.06
PEG Ratio
13.43
Div. Yield
1.61%
ROE
3.03%
Beta
0.736
Debt to Equity
30.99
Financial Highlights
Profitability
Gross Margin
58.43%
Operating Margin
-2.47%
Profit Margin
1.89%
Returns and Earnings
Return on Assets (TTM)
1.49%
Return on Equity (TTM)
3.03%
EBITDA
€48.2M
Net Income (TTM)
€6.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€4.21
Quarterly Revenue Growth (YoY)
-6.90%
Quarterly Earnings Growth (YoY)
110.83%
Dividend Information
Last 12-Month Dividend
€0.05
Current Dividend Yield
1.61%
3-Year Average Dividend Yield
8.04%
3-Year Average Annual Dividend
€0.38
3-Year Total Dividends
€1.13
Ex-Dividend Date
May 15, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Laboratorio Reig RJF | 229.52M Mid-cap | -0.35% | -4.05% | -8.09% | 7.58% | 10.51% | 3.65% | 25.66% | -33.18% |
| Laboratorios ROVI | 3.04B Large-cap | -1.84% | 1.82% | 8.89% | 11.79% | -8.13% | -18.56% | 33.03% | 89.68% |
| Almirall S.A ALM | 2.49B Large-cap | 3.76% | 3.57% | 9.23% | 14.51% | 38.42% | 31.07% | 17.65% | 20.08% |
| Faes Farma S.A FAE | 1.31B Large-cap | 0.47% | -0.24% | -6.19% | 20.11% | 20.80% | 14.29% | 14.29% | 26.19% |
| Labiana Health S.A LAB | 28.89M Small-cap | 0.00% | 2.04% | 9.89% | 35.14% | 36.05% | 60.00% | 13,233.33% | 640.74% |
| Grifols, S.A GRF | 7.45B Large-cap | -0.83% | -3.95% | 17.57% | 29.60% | 25.90% | 17.34% | 34.12% | -52.40% |
Ownership & Short Interest
Insider Ownership
77.76%
Institutional Ownership
1.34%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
20K
Average 90-Day Volume
24K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RJF's 52-week high and low?
- In the last 52 weeks, Laboratorio Reig reached a high of €3.40 (on June 6, 2025) and a low of €2.46 (on January 16, 2025).
- What is the market cap and P/E ratio for RJF?
- Curious about Laboratorio Reig's size and valuation? Its market capitalization stands at 229.52M. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.25, and the forward P/E (looking ahead) is 13.43.
- Does RJF pay dividends? If so, what's the yield?
- Yes, Laboratorio Reig is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.61%, and the company has paid an average of €0.38 per share annually over the past 3 years.
- Who are Laboratorio Reig's main competitors or similar companies to consider before investing?
When looking at Laboratorio Reig, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI3.04B Healthcare Drug Manufacturers - Specialty & Generic -18.56% 33.03% Almirall S.A
ALM2.49B Healthcare Drug Manufacturers - Specialty & Generic 31.07% 17.65% Faes Farma S.A
FAE1.31B Healthcare Drug Manufacturers - Specialty & Generic 14.29% 14.29% Labiana Health S.A
LAB28.89M Healthcare Drug Manufacturers - Specialty & Generic 60.00% 13,233.33% Grifols, S.A
GRF7.45B Healthcare Drug Manufacturers - General 17.34% 34.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Laboratorio Reig Jofre S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Laboratorio Reig's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.03%, the Debt to Equity ratio from the most recent quarter is 30.99, and its Gross Profit Margin stands at 58.43%.
- What is the recent revenue and earnings growth for RJF?
- Looking at Laboratorio Reig's growth, its revenue over the trailing twelve months (TTM) was €337M. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.90%, and quarterly earnings saw a YoY growth of 110.83%.
- How much of RJF stock is held by insiders and institutions?
- Wondering who owns Laboratorio Reig stock? Company insiders (like executives and directors) hold about 77.76% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.34%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.